×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: covid-19 | veterinary | drug | mortality | pandemic | treatments | veterinary

Veterinary Drug Associated With Lower Mortality for COVID

Chloroquine, Hydroxychloroquine Sulfate, Zinc, Ivermectin and Avigan drugs sitting on a table
(Dreamstime/Sergio Yoneda)

By    |   Tuesday, 13 October 2020 04:33 PM EDT

A drug originally developed in the 1970s as a veterinary medicine to combat parasites in livestock was associated with lower death rates among people suffering from COVID-19, a study conducted in Florida and published in the medical journal Chest revealed.

Patients who received ivermectin, which was called a "wonder drug" in a study a decade ago for the treatment of the parasitic diseases, river blindness – or onchocerciasis – and lymphatic filariasis, had a mortality rate of 15% compared to 25% who did not receive the drug. The results were even more significant for COVID-19 patients with "severe pulmonary involvement."

The mortality rate was only 38% for those patients who received ivermectin compared with 80.7% for the patients that did not receive it.

Most patients in both groups also received hydroxychloroquine and/or azithromycin.

"In this multihospital retrospective cohort study, we observed a significant association with ivermectin on improved survival for patients admitted with COVID-19," the authors said. "This association was also seen in the subset of patients with severe pulmonary disease."

Ivermectin was shown to inhibit replication of the SARS-CoV-2 virus that causes COVID-19 in laboratory tests, which led to "off-label" use, the study's authors said in their report. That led to a warning by the Food & Drug Administration on April 10 against its use.

The Florida researchers reviewed the treatment and results of 280 COVID-19 patients hospitalized at four Broward Health hospitals between March 15 and May 11.

One hundred seventh-three patients were treated with ivermectin and 107 were not.

"After multivariate adjustment for confounders and mortality risks, the mortality difference remained significant," the authors said, 13.3% for the ivermectin-treated patients versus 24.5% without.

© 2022 Newsmax. All rights reserved.


US
A drug originally developed in the 1970s as a veterinary medicine to combat parasites in livestock was associated with lower death rates among people suffering from COVID-19, a study conducted in Florida and published in the medical journal Chest revealed.
covid-19, veterinary, drug, mortality, pandemic, treatments, veterinary, medicine
276
2020-33-13
Tuesday, 13 October 2020 04:33 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved